ELVAF
Price
$1.10
Change
-$0.05 (-4.35%)
Updated
Oct 10 closing price
Capitalization
7.64M
Intraday Buy/Sell Signals
SIGY
Price
$2.10
Change
+$0.05 (+2.44%)
Updated
Oct 10 closing price
Capitalization
3.37M
Intraday Buy/Sell Signals
Interact to see
Advertisement

ELVAF vs SIGY

Header iconELVAF vs SIGY Comparison
Open Charts ELVAF vs SIGYBanner chart's image
EVONEXT HLDGS SA
Price$1.10
Change-$0.05 (-4.35%)
Volume$800
Capitalization7.64M
Sigyn Therapeutics
Price$2.10
Change+$0.05 (+2.44%)
Volume$200
Capitalization3.37M
ELVAF vs SIGY Comparison Chart in %
ELVAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVAF vs. SIGY commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVAF is a Hold and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (ELVAF: $1.10 vs. SIGY: $2.10)
Brand notoriety: ELVAF and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVAF: 188% vs. SIGY: 15%
Market capitalization -- ELVAF: $7.64M vs. SIGY: $3.37M
ELVAF [@Biotechnology] is valued at $7.64M. SIGY’s [@Biotechnology] market capitalization is $3.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVAF’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • ELVAF’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVAF is a better buy in the long-term than SIGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVAF’s TA Score shows that 1 TA indicator(s) are bullish while SIGY’s TA Score has 3 bullish TA indicator(s).

  • ELVAF’s TA Score: 1 bullish, 1 bearish.
  • SIGY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ELVAF is a better buy in the short-term than SIGY.

Price Growth

ELVAF (@Biotechnology) experienced а -4.35% price change this week, while SIGY (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVAF($7.64M) has a higher market cap than SIGY($3.37M). ELVAF YTD gains are higher at: 22.222 vs. SIGY (-33.333). ELVAF has higher annual earnings (EBITDA): -848.8K vs. SIGY (-2.39M). ELVAF has more cash in the bank: 6.31M vs. SIGY (12.9K). ELVAF (0) and SIGY (0) have equivalent revenues.
ELVAFSIGYELVAF / SIGY
Capitalization7.64M3.37M227%
EBITDA-848.8K-2.39M36%
Gain YTD22.222-33.333-67%
P/E Ratio5.19N/A-
Revenue00-
Total Cash6.31M12.9K48,938%
Total DebtN/A2.51M-
FUNDAMENTALS RATINGS
ELVAF vs SIGY: Fundamental Ratings
ELVAF
SIGY
OUTLOOK RATING
1..100
3892
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
4197
P/E GROWTH RATING
1..100
51100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELVAF's Valuation (41) in the null industry is somewhat better than the same rating for SIGY (78). This means that ELVAF’s stock grew somewhat faster than SIGY’s over the last 12 months.

ELVAF's Profit vs Risk Rating (100) in the null industry is in the same range as SIGY (100). This means that ELVAF’s stock grew similarly to SIGY’s over the last 12 months.

ELVAF's SMR Rating (95) in the null industry is in the same range as SIGY (100). This means that ELVAF’s stock grew similarly to SIGY’s over the last 12 months.

ELVAF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for SIGY (97). This means that ELVAF’s stock grew somewhat faster than SIGY’s over the last 12 months.

ELVAF's P/E Growth Rating (51) in the null industry is somewhat better than the same rating for SIGY (100). This means that ELVAF’s stock grew somewhat faster than SIGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELVAFSIGY
RSI
ODDS (%)
Bearish Trend 8 days ago
71%
Bullish Trend 8 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
60%
Bullish Trend 8 days ago
71%
Momentum
ODDS (%)
N/A
Bearish Trend 8 days ago
76%
MACD
ODDS (%)
N/A
Bearish Trend 8 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
30%
Bearish Trend 8 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
27%
Bearish Trend 8 days ago
72%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 8 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 8 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ELVAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FXNC22.370.59
+2.73%
First National Corp
CCI97.291.19
+1.24%
Crown Castle
GRPN21.430.25
+1.18%
Groupon
COHN10.890.08
+0.74%
Cohen & Company
PHI18.99-0.05
-0.26%
PLDT

ELVAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVAF has been closely correlated with WHWK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if ELVAF jumps, then WHWK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVAF
1D Price
Change %
ELVAF100%
N/A
WHWK - ELVAF
76%
Closely correlated
-3.43%
CLYYF - ELVAF
47%
Loosely correlated
N/A
GLABF - ELVAF
34%
Loosely correlated
N/A
SIGY - ELVAF
31%
Poorly correlated
N/A
WXXWY - ELVAF
31%
Poorly correlated
-2.71%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and ELVAF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and ELVAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
ELVAF - SIGY
31%
Poorly correlated
N/A
IVVD - SIGY
20%
Poorly correlated
-13.30%
CLYYF - SIGY
12%
Poorly correlated
N/A
NBTX - SIGY
11%
Poorly correlated
-6.86%
CPMV - SIGY
6%
Poorly correlated
N/A
More